SB1034,42,4
24(3) Prosecution. (a) A person who is acting in accordance with this section and
25s. 73.17 or 73.18 may not be prosecuted for a criminal offense under this chapter, or
1under any municipal ordinance that prohibits conduct that is the same as that
2prohibited under this chapter, for the possession, manufacture, distribution, or
3delivery of marijuana or possession with the intent to manufacture, distribute, or
4deliver marijuana.
SB1034,42,135
(b) A licensed entity or an agent or employee of a licensed entity who possesses,
6manufactures, distributes, or delivers marijuana or possesses with the intent to
7manufacture, distribute, or deliver marijuana in violation of s. 73.17 or in violation
8of a rule promulgated under s. 73.17 may not be prosecuted under this chapter unless
9the person is referred to the district attorney for the county in which the violation
10occurred by the medical marijuana regulatory commission and may not be
11prosecuted under a municipal ordinance that prohibits the same conduct as is
12prohibited under this chapter unless the person is referred to local law enforcement
13by the medical marijuana regulatory commission.
SB1034,42
14Section 42
. 961.38 (title) of the statutes is amended to read:
SB1034,42,15
15961.38 (title)
Prescriptions and recommendations for medical use.
SB1034,43
16Section 43
. 961.38 (1p) of the statutes is created to read:
SB1034,42,1917
961.38
(1p) A dispensary licensed under s. 73.17 may dispense medical
18marijuana to a person with a valid written hard copy or electronic recommendation
19and a valid registry identification card in accordance with s. 73.18.
SB1034,44
20Section 44
. 961.385 (1) (aj) of the statutes is amended to read:
SB1034,42,2421
961.385
(1) (aj) “Patient" means an individual or animal for whom a monitored
22prescription drug is prescribed
or, to whom a monitored prescription drug is
23dispensed or administered
, or for whom the use of medical marijuana is
24recommended under s. 73.18 (2).
SB1034,45
25Section 45
. 961.385 (2) (intro.) of the statutes is amended to read:
SB1034,43,4
1961.385
(2) (intro.) The board shall establish by rule a program for monitoring
2the dispensing of monitored prescription drugs
and the making of recommendations
3for the use of, and issuance of registry identification cards for, medical marijuana.
4The program shall do all of the following:
SB1034,46
5Section 46
. 961.385 (2) (am) and (an) of the statutes are created to read:
SB1034,43,86
961.385
(2) (am) Require a practitioner to generate a record documenting each
7recommendation made by the practitioner for the use of medical marijuana under s.
873.18 (2).
SB1034,43,109
(an) Require the medical marijuana regulatory commission to generate a
10record documenting the issuance of a registry identification card under s. 73.18 (3).
SB1034,47
11Section 47
. 961.385 (2) (b) of the statutes is amended to read:
SB1034,43,1412
961.385
(2) (b) Identify specific data elements to be contained in a record
13documenting the dispensing of a monitored prescription drug, including the method
14of payment and, subject to sub. (2m), the name recorded under s. 450.11 (1b) (bm).
SB1034,43,18
15(bm) In identifying specific data elements
, the board shall under pars. (b), (bc),
16and (bd), consider data elements identified by similar programs in other states and
17shall ensure, to the extent possible, that records generated by the program are easily
18shared with other states.
SB1034,48
19Section 48
. 961.385 (2) (bc) and (bd) of the statutes are created to read:
SB1034,43,2220
961.385
(2) (bc) Identify specific data elements to be contained in a record
21documenting the making of a recommendation for the use of medical marijuana
22under s. 73.18 (2).
SB1034,43,2423
(bd) Identify specific data elements to be contained in a record documenting the
24issuance of a registry identification card under s. 73.18 (3).
SB1034,49
25Section 49
. 961.385 (2) (cm) 3. a. of the statutes is amended to read:
SB1034,44,6
1961.385
(2) (cm) 3. a. The state board or agency, agency of another state, law
2enforcement agency, or prosecutorial unit makes a written request for the record and
3is engaged in an active and specific investigation or prosecution of a violation of any
4state or federal law involving a monitored prescription drug
or any state or federal
5law involving marijuana, and the record being requested is reasonably related to
6that investigation or prosecution.
SB1034,50
7Section 50
. 961.385 (2) (cs) 1. of the statutes is amended to read:
SB1034,44,138
961.385
(2) (cs) 1. Require that a patient's records under the program be
9reviewed before the practitioner issues a prescription order for the patient
or before
10the practitioner makes a recommendation to the patient for the use of medical
11marijuana under s. 73.18 (2). The review required under this subdivision may be
12performed by the practitioner or by the practitioner's agent in accordance with
13applicable standards of practice. This subdivision does not apply after April 1, 2025.
SB1034,51
14Section 51
. 961.385 (2) (cs) 2. (intro.), b., c. and d. of the statutes are amended
15to read:
SB1034,44,1816
961.385
(2) (cs) 2. (intro.) The
requirement requirements under subd. 1.
that
17a patient's records under the program be reviewed before the practitioner issues a
18prescription order for the patient does do not apply if any of the following is true:
SB1034,44,2119
b. The
practitioner is issuing a prescription order
is for
a monitored
20prescription drug for a number of doses that is intended to last the patient 3 days or
21less and is not subject to refill.
SB1034,44,2222
c.
The A monitored prescription drug is lawfully administered to the patient.
SB1034,45,223
d. Due to emergency, it is not possible to review the patient's records under the
24program before the practitioner issues a prescription order for the patient
or before
1the practitioner makes a recommendation to the patient for the use of medical
2marijuana under s. 73.18 (2).
SB1034,52
3Section 52
. 961.55 (8) (c) of the statutes is created to read:
SB1034,45,54
961.55
(8) (c) A license from the medical marijuana regulatory commission
5under s. 73.17.